Fresh vs Frozen Embryo Transfer: How Your Fertility Team Decides Which Path Fits Your Cycle

The call comes on the afternoon of egg retrieval, or the morning after. You have been counting follicles on a monitor for two weeks, sorting syringes on the kitchen counter, watching your estrogen numbers climb. Then the embryologist or nurse says a sentence you had not braced for: the team thinks it would be better to freeze everything and transfer next month.

For many people, that pause lands like a setback. It rarely is one. The question of fresh vs frozen embryo transfer is less a fork in the road than a matter of timing, and the choice is driven by biology that is visible on the ultrasound and in the bloodwork, not by anyone’s preference for one path.

This explainer walks through what each transfer involves, what the higher-quality evidence actually shows about outcomes, why a team might ask you to wait, and what the days after transfer tend to look like. Every decision in it belongs to you and the clinicians who know your cycle.

What is the difference between a fresh vs frozen embryo transfer?

An embryo transfer is the step in in vitro fertilization (IVF) where an embryo created in the laboratory is placed into the uterus through a thin, soft catheter passed through the cervix. It usually takes a few minutes and does not need anesthesia. What distinguishes fresh from frozen is not the transfer itself but when it happens relative to egg retrieval.

In a fresh transfer, the embryo goes back in the same cycle in which the eggs were collected. Mayo Clinic describes the transfer window as roughly two to six days after retrieval, once the embryo has developed in culture. The ovaries have just been stimulated, so the body is still flooded with hormones from many growing follicles.

In a frozen embryo transfer (FET), embryos are preserved using vitrification, an ultra-rapid cooling technique that turns the water inside cells into a glass-like state rather than ice crystals, which is what damaged embryos under older slow-freezing methods. The embryos wait in liquid nitrogen while the body returns to baseline. Weeks or months later, in a separate cycle, the uterine lining is prepared and a thawed embryo is transferred.

A third term you will hear is the freeze-all cycle: a deliberate plan to freeze every usable embryo and skip the fresh transfer entirely. Sometimes this is decided before stimulation begins; often it is decided during the cycle when monitoring reveals a reason to wait.

One embryo, two calendars. The laboratory work is nearly identical. The difference lies in whether the uterus receives the embryo in a hormonally stormy week or in a calmer, more controlled one, and that distinction is the whole reason the debate exists.

How does a fresh embryo transfer actually work, step by step?

A fresh cycle starts with ovarian stimulation. Injectable fertility medicines belonging to the gonadotropin class, hormones that mimic the body’s own follicle-stimulating signals, encourage several follicles to grow at once instead of the usual one. Your team tracks growth with transvaginal ultrasound and blood tests for estrogen. The prescribing clinician sets and adjusts everything; there is no standard recipe.

When the follicles reach a target size, a trigger injection prompts the final maturation of the eggs. According to Mayo Clinic, egg retrieval is timed about 34 to 36 hours after that trigger, before the follicles would release on their own. Retrieval is a short procedure under sedation: a needle guided by ultrasound draws fluid, and the eggs within it, from each follicle.

In the laboratory, eggs meet sperm the same day, either mixed together in a dish or through intracytoplasmic sperm injection (ICSI), in which a single sperm is injected into an egg. Embryologists then watch development. Day three embryos, called cleavage-stage embryos, have roughly six to ten cells. By day five or six, a healthy embryo becomes a blastocyst, a hollow ball with an inner cluster that will become the fetus and an outer layer that becomes the placenta.

Transfer happens somewhere in that window. Progesterone support, a hormone that stabilizes the uterine lining, is usually prescribed from around retrieval onward because the retrieval process disturbs the ovaries’ natural progesterone production. Mayo Clinic notes that a blood pregnancy test typically follows about 12 days to two weeks after retrieval.

The whole sequence, from the first injection to the pregnancy test, is compressed into a single menstrual cycle. That speed is the fresh transfer’s main appeal, and, as the next sections explain, sometimes its main problem.

What happens in a frozen embryo transfer, from thaw to transfer?

A frozen cycle separates the two halves of IVF. The retrieval and fertilization have already happened; now the job is to prepare the uterus and match its readiness to the age of the embryo.

Preparation follows one of two broad approaches, covered in more detail later. In a natural or modified natural cycle, the team tracks your own ovulation and times the transfer to it. In a medicated cycle, estrogen is given first to thicken the lining, then progesterone is added to make it receptive, with ovulation suppressed so the timing is controlled entirely by the medication schedule. Which approach suits you is a clinical decision based on how regularly you ovulate, your history, and practical considerations.

The lining is checked by ultrasound. Clinicians look at its thickness and at its pattern, the layered appearance that suggests estrogen has done its work. If the lining is not where the team wants it, the transfer may be postponed rather than forced.

Thawing is the step people worry about most. Embryologists warm the embryo rapidly, rehydrate it in a series of solutions, and then assess it under the microscope. Most vitrified embryos survive this process intact, though survival is never guaranteed and the team will discuss what happens if an embryo does not recover. A blastocyst frozen on day five is transferred on what the prepared lining treats as day five after ovulation, so embryo and endometrium are synchronized.

The transfer itself is identical to a fresh one: a speculum, a catheter, a brief moment on the ultrasound screen as a small flash of fluid marks where the embryo has been placed. The difference is everything that came before, especially the absence of a freshly stimulated ovary sending hormones into the mix.

Fresh vs frozen embryo transfer: what does the evidence actually show?

For years, frozen transfers were seen as the consolation prize. That reputation was earned under slow-freezing, when a meaningful share of embryos did not survive the thaw. Vitrification changed the laboratory picture so thoroughly that the question flipped: some clinicians began to argue that freezing everything and transferring later was better for everyone.

The most rigorous synthesis of the evidence does not support either extreme. A Cochrane systematic review of randomized trials comparing freeze-all strategies with fresh transfer concluded there is probably little or no difference in cumulative live birth rate between the two approaches, with moderate-certainty evidence. Cumulative live birth means the chance of a baby from one retrieval, counting all transfers from that batch of embryos. On the measure that matters most, the paths appear broadly comparable.

The review did find differences in the shape of the journey. Ovarian hyperstimulation syndrome (OHSS), an overreaction to stimulation in which fluid shifts out of blood vessels, was less frequent with freeze-all, which makes sense because pregnancy hormones in a fresh cycle can worsen it. The freeze-all group also took longer to achieve pregnancy, simply because they waited a cycle. On the other side of the ledger, the review reported a higher risk of hypertensive disorders of pregnancy and of babies born large for gestational age after frozen transfer.

Two honest caveats. The trials included in such reviews often enrolled people who respond strongly to stimulation, so findings may not translate cleanly to everyone. And much of the debate rests on observational registry data, which can be biased by the fact that patients sent to freeze-all often had more follicles to begin with. The evidence-based summary is unglamorous: neither path is superior across the board, and the right one depends on the person in the chair.

Is IVF more successful with fresh or frozen eggs?

This is the question people type most often, and it hides a mix-up worth untangling. Freezing eggs and freezing embryos are different procedures with different track records, and most fresh vs frozen debates in IVF are about embryos, not eggs.

An egg is a single, large, water-rich cell. That makes it more delicate during cooling and warming than an embryo, which has multiple cells and can lose one or two without stalling. Egg freezing is used mainly for fertility preservation, for instance before cancer treatment or for people who want to delay trying to conceive, and in donor egg programs. Embryo freezing is a routine part of nearly every IVF cycle that produces more than one usable embryo.

With vitrification, the laboratory performance of frozen eggs has improved substantially, but comparisons with fresh eggs are complicated by who freezes them and why. Age at the time of freezing is the dominant factor in whether frozen eggs later produce a healthy embryo, more than the freezing itself. Mainstream sources such as Mayo Clinic frame egg freezing as an option with no guarantee of a future pregnancy, and the same caution applies to any comparison with fresh eggs.

For embryos, the picture is clearer and the earlier Cochrane findings apply: comparable cumulative live birth, with different risk profiles. A helpful way to think about it is that freezing is a storage decision, not a quality decision. A well-developed embryo that survives thaw is the same embryo it was before, and the outcome depends far more on its chromosomal makeup, the age of the eggs it came from, and the uterine environment than on whether it spent time in liquid nitrogen.

If you are weighing egg freezing specifically, ask your team for data relevant to your age group rather than headline figures, which are rarely broken down in the way that matters to an individual.

Who is usually offered a fresh transfer, and who is asked to wait?

The decision to go fresh or freeze is often made in the last days of stimulation, when the monitoring data comes into focus. Several findings push teams toward waiting.

The first is OHSS risk. When estrogen levels are very high and many follicles are developing, the ovaries are primed to react badly after the trigger, and a pregnancy in that same cycle produces its own hormone, human chorionic gonadotropin, which can prolong and intensify the syndrome. Freezing embryos removes that second hit. The NHS lists OHSS among the recognized risks of IVF and notes it is more likely in people who respond strongly to stimulation.

The second is a premature rise in progesterone before the trigger. Progesterone changes the lining’s timing; if it climbs too early, the window of receptivity may open before the embryo is ready. Many teams prefer to freeze and try again with a synchronized lining.

The third is genetic testing. Preimplantation genetic testing for aneuploidy (PGT-A) means removing a few cells from the blastocyst’s outer layer and analyzing the chromosomes. Results take days, longer than a fresh transfer allows, so PGT-A cycles are almost always freeze-all.

Other reasons include a lining that looks thin or uneven on ultrasound, fluid seen in the uterine cavity, a medical issue that surfaces during the cycle, or the need to coordinate with surgery or cancer treatment.

Who tends to proceed fresh? Typically someone with a moderate response to stimulation, estrogen in a range the team considers safe, progesterone that has stayed low, a lining that looks ready, and no plan for genetic testing. Some teams also lean toward fresh transfer when the number of embryos is small, to avoid any thaw-related loss.

None of these rules is absolute. They are patterns, and your team weighs them against your history and preferences.

Fresh vs frozen embryo transfer at a glance

The table below distills the differences described so far. It is a map of typical patterns drawn from mainstream sources, not a scorecard, and individual cycles regularly depart from it.

Feature	Fresh transfer	Frozen transfer
Timing	Same cycle as retrieval, about two to six days later (Mayo Clinic)	A later menstrual cycle, weeks to months afterward
Hormonal environment	Elevated estrogen from stimulated ovaries	Body back at baseline; lining prepared naturally or with medication
Cumulative live birth	Probably little or no difference between strategies (Cochrane review, moderate certainty)
OHSS risk	Higher, especially if pregnancy occurs	Lower (Cochrane review)
Pregnancy complications	Lower reported rates of hypertensive disorders	Higher reported rates of hypertensive disorders and large-for-gestational-age babies (Cochrane review)
Time to pregnancy	Shorter	Longer, by at least one cycle
Compatible with PGT-A	Rarely; results take too long	Yes, standard approach
Thaw risk	None	Small chance an embryo does not survive warming
Flexibility	Fixed by the stimulation calendar	Can be scheduled around health, work, and recovery

Read across a row and the trade-offs become visible. Fresh transfer buys time and avoids thawing but carries the hormonal baggage of stimulation. Frozen transfer buys safety from OHSS and room for genetic testing but adds a wait and shifts the risk profile toward the later stages of pregnancy.

What the table cannot show is the individual context: how you responded, what your lining looked like, how many embryos you have, and how you feel about waiting. Those variables are why the same two columns produce different recommendations for different people.

Natural vs medicated FET: is one approach better?

Once a frozen transfer is planned, a second decision follows: how to prepare the lining. The two main routes differ in how much they lean on the body’s own hormones.

In a natural cycle FET, the team monitors your ovulation with ultrasound and blood tests, sometimes with a trigger injection to pin down the timing precisely (a modified natural cycle). The corpus luteum, the structure left behind after an egg is released, produces its own progesterone and other signals. Transfer is timed to your ovulation. This route needs regular cycles and more monitoring appointments, and there is always a chance ovulation happens unexpectedly and the transfer must be rescheduled.

In a medicated FET, also called an artificial or programmed cycle, estrogen is given to build the lining while ovulation is suppressed, then progesterone is added to open the receptive window. No corpus luteum forms, so the medication does all the work, usually until the placenta takes over hormone production in early pregnancy. The appeal is control: the transfer date is set in advance, which suits people with irregular cycles or those coordinating with donor embryos.

Does either approach produce more babies? The honest answer is that high-quality trials have not shown a consistent winner for live birth, and reviews of endometrial preparation methods have generally found the evidence insufficient to favor one route. Researchers are actively studying whether the absence of a corpus luteum in medicated cycles relates to the higher rates of hypertensive disorders seen after frozen transfer, since the corpus luteum releases substances involved in blood vessel adaptation in early pregnancy. That hypothesis is plausible and under investigation; it is not settled.

Your team’s choice will reflect your ovulation pattern, your history, and the logistics of your life. Ask them to explain their reasoning, and expect a real answer rather than a slogan.

Which embryo has the highest success rate: day 3, day 5, or tested?

People searching for the “best” embryo are usually trying to understand three things: the day of development, the grade the embryologist assigns, and whether genetic testing has been done.

Development stage comes first. A day three embryo is a compact cluster of cells; a day five embryo has become a blastocyst with distinct inner and outer layers. Extending culture to day five lets weaker embryos reveal themselves before transfer, so blastocyst transfer tends to involve a stronger selection process. The trade-off is that some embryos that might have implanted if transferred on day three do not reach blastocyst in the laboratory, and a cycle can end with fewer embryos than expected. Reviews comparing the two stages have generally found blastocyst transfer associated with higher live birth per transfer but no clear advantage in cumulative live birth once all embryos from a retrieval are counted.

Grading is the embryologist’s visual assessment of expansion, the inner cell mass, and the outer layer. Higher grades correlate with better outcomes on average, but grading is subjective, and lower-graded embryos produce healthy babies regularly. Mayo Clinic describes embryo appearance and stage as factors clinicians weigh, not verdicts.

Chromosomal status matters more than either. An embryo with a normal chromosome count, called euploid, is more likely to implant and less likely to miscarry than one with an abnormal count, and the proportion of euploid embryos falls with the age of the eggs. PGT-A can identify euploid embryos, though it requires freezing, involves a biopsy, and is not recommended for everyone; the evidence for who benefits is still debated.

The answer to “which embryo has the highest success rate” is therefore not a category but a profile: a well-developed embryo, from eggs retrieved at a younger age, transferred into a synchronized lining. Ask your team how those factors apply to your embryos rather than chasing a universal ranking.

What do the days and weeks after an embryo transfer usually look like?

The transfer takes minutes. The wait that follows feels far longer, and knowing the typical shape of it helps.

Immediately afterward, Mayo Clinic notes that most people can resume normal daily activities. Bed rest is not required and has not been shown to help. Mild cramping, a little bloating, and light spotting can occur and are usually related to the catheter or to the hormones you are taking rather than to whether implantation is happening. In a fresh cycle, your ovaries are still enlarged, so they may feel tender for a week or more, and your team will likely ask you to avoid vigorous exercise that could twist an enlarged ovary.

Progesterone support continues throughout. Its side effects, breast tenderness, fatigue, mood shifts, and mild nausea, overlap almost perfectly with early pregnancy symptoms, which is why symptom-watching in this window is so unreliable. Many people find it steadier to plan distractions than to interpret every twinge.

The blood pregnancy test typically falls around 12 days to two weeks after retrieval in a fresh cycle, per Mayo Clinic, and at a comparable interval after transfer in a frozen cycle. Home urine tests can mislead in either direction, especially soon after a trigger injection, so most teams ask you to wait for the blood result.

If the test is positive, expect repeat blood tests to confirm the level is rising appropriately, then an early ultrasound a few weeks later to check location and heartbeat. Medication support usually continues until the team confirms the placenta has taken over. Care then transitions to your obstetric provider.

If the test is negative, the team will tell you when to stop supportive medication; a period generally follows within days. If frozen embryos remain, a subsequent FET can often be planned for the following cycle or after a break, depending on how you feel and what your clinicians advise.

What are the risks and trade-offs on each path?

Neither route is risk-free, and the risks are distributed differently across the timeline.

Fresh transfer carries the greater short-term hazard: OHSS. In this syndrome, the stimulated ovaries release substances that make blood vessels leaky, so fluid collects in the abdomen and occasionally around the lungs while the bloodstream becomes concentrated and prone to clotting. The NHS describes mild cases, marked by bloating and discomfort, as relatively common after stimulation, and severe cases, involving rapid swelling, vomiting, reduced urination, and breathlessness, as uncommon but serious enough to need hospital care. Because the pregnancy hormone hCG prolongs OHSS, a pregnancy from a fresh transfer can turn a mild case into a severe one. Freezing embryos is the main tool teams use to prevent that.

Frozen transfer shifts the risk toward the pregnancy itself. The Cochrane review found higher rates of hypertensive disorders of pregnancy, including preeclampsia, and more babies born large for gestational age after frozen transfer compared with fresh. The absolute differences are modest and the mechanisms are still being studied, but they are consistent enough that obstetric teams take note of a frozen-transfer conception when planning prenatal monitoring.

Both paths share the risks common to IVF as a whole. The NHS lists multiple pregnancy when more than one embryo is transferred, ectopic pregnancy, medication side effects, and the emotional strain of treatment. Single embryo transfer has become the default in many settings precisely because twins carry more risk for both parent and babies.

Frozen cycles add one laboratory risk fresh cycles avoid: an embryo may not survive warming. With vitrification this is uncommon, but it is not zero, and it weighs more heavily when only one or two embryos exist.

The alternative to both, of course, is not transferring at the moment, whether to recover, to reconsider, or to pursue other options. That, too, is a legitimate choice your team should be willing to discuss.

What people often get wrong about fresh and frozen transfers

Fertility forums are generous with confident claims. A few deserve correction.

“Being told to freeze means something went wrong.” Usually it means something went right: a strong response produced many follicles, and the team is protecting you from OHSS. A freeze-all recommendation is a safety decision far more often than a sign of trouble.

“Frozen embryos are weaker than fresh ones.” Under slow freezing, loss was real. Under vitrification, an embryo that survives warming is the same embryo. The Cochrane review’s finding of comparable cumulative live birth is the clearest rebuttal.

“Frozen is always better, so everyone should freeze.” Also unsupported. The same review shows a longer time to pregnancy and higher rates of hypertensive disorders and large babies with freeze-all. The trials mostly enrolled high responders, so the benefits may not extend to people with moderate responses.

“Resting in bed after transfer improves the odds.” There is no good evidence for this, and Mayo Clinic notes normal activity can resume. Prolonged immobility raises clot risk, which matters more in a fresh cycle when the blood is already concentrated.

“Symptoms in the two-week wait tell you the result.” Progesterone mimics early pregnancy almost perfectly. Only the blood test knows.

“A home test a few days after transfer is reliable.” A trigger injection contains hCG, the very hormone pregnancy tests detect, and it can linger for well over a week. False positives and false negatives are both common before the scheduled blood draw.

“Embryos spoil in storage.” At liquid nitrogen temperatures, biological activity effectively stops. The NHS notes embryos can be stored for years and used in later cycles; the practical limits are regulatory and personal, not biological.

Correcting these ideas is not pedantry. Each one shapes how people feel when a plan changes, and the feeling that freezing equals failure causes real, unnecessary grief.

Questions to ask your care team about your transfer plan

A good consultation leaves you understanding not just what the plan is but why it fits you. These questions tend to open that conversation.

• Based on my monitoring so far, do you expect a fresh transfer or a freeze-all cycle, and which findings would change that?
• What estrogen levels, follicle counts, or progesterone values would prompt you to freeze rather than transfer fresh?
• Do you recommend PGT-A for me, and what does the evidence say about who benefits from it?
• If we freeze, how soon could a frozen transfer take place, and would you use a natural or medicated cycle to prepare my lining?
• How many embryos do you plan to transfer, and why? What is your approach to single embryo transfer?
• What is your laboratory’s experience with vitrification, and what happens if an embryo does not survive thawing?
• How will my OHSS risk be monitored, and what symptoms should make me call?
• If I conceive from a frozen transfer, how will that affect my prenatal monitoring for blood pressure?
• What is the plan if the lining does not look ready on the day?
• Whom do I contact after hours, and what counts as an emergency?

Bring someone with you if you can, or ask whether you may record the conversation for later review. Decisions made in the middle of a stimulation cycle arrive quickly, and having the logic explained in advance makes a same-day change of plan feel like part of the process rather than a rupture.

If an answer is “we don’t know for certain,” treat it as a good sign. The evidence on several of these questions is genuinely unsettled, and a team that says so is being straight with you.

When to call your doctor

Most people move through retrieval and transfer with nothing worse than bloating and fatigue. A small number develop complications that need prompt attention, and the days after a fresh cycle are the highest-risk window because the ovaries are still enlarged and OHSS can escalate.

Contact your fertility team the same day, or seek urgent care if you cannot reach them, for any of the following:

• Rapid abdominal swelling or sudden, noticeable weight gain over a day or two
• Severe or worsening abdominal pain, especially if it is one-sided or comes with dizziness
• Persistent vomiting or inability to keep fluids down
• Passing much less urine than usual, or urine that is dark despite drinking
• Shortness of breath, chest pain, or difficulty lying flat
• Pain, swelling, or redness in one calf
• Heavy vaginal bleeding that soaks through pads, or bleeding with clots
• Fever, chills, or foul-smelling discharge after a procedure
• Fainting or feeling close to fainting

The first six signs on that list are the classic pattern of moderate to severe OHSS or a blood clot, both of which the NHS and Cleveland Clinic describe as complications that require medical assessment. One-sided pain with dizziness in early pregnancy can also signal an ectopic pregnancy, which needs urgent evaluation.

Emotional distress deserves the same seriousness. If the waiting or a negative result leaves you unable to function, sleep, or feel safe, tell your team; most fertility services can connect you with counseling, and asking is not weakness.

Nothing in this article replaces the judgment of the clinicians who have seen your scans and your bloodwork. When in doubt, call. Teams would far rather hear from you about a symptom that turns out to be benign than learn later that you waited.

Frequently asked questions

Is IVF more successful with fresh or frozen eggs?

For embryos, high-quality evidence shows comparable cumulative live birth between fresh and frozen strategies. Eggs are a different story: a single water-rich cell is more fragile to freeze than an embryo, and outcomes with frozen eggs depend heavily on the age at which they were frozen. Mainstream sources describe egg freezing as an option without a guaranteed outcome, so ask your team for age-specific information rather than general comparisons.

What are the success rates for a 5-day fresh embryo transfer?

No single figure applies to everyone, and this article does not quote clinic-specific rates. Outcomes for a day five, or blastocyst, transfer depend mainly on the age of the eggs, the chromosomal status of the embryo, and the readiness of the uterine lining. Reviews suggest blastocyst transfer raises live birth per transfer but not necessarily cumulative live birth per retrieval. Your team can interpret published data for your circumstances.

Which embryo has the highest success rate?

An embryo with a normal chromosome count, from eggs retrieved at a younger age, that has developed to a well-graded blastocyst, transferred into a synchronized lining. Chromosomal status is the strongest of these factors. Grading is useful but subjective, and lower-graded embryos produce healthy babies regularly, so no visual category guarantees or rules out a pregnancy.

Is a natural or medicated FET better?

Trials have not shown a consistent live birth advantage for either approach, and reviews of lining preparation generally find the evidence insufficient to favor one. Natural cycles rely on your own ovulation and corpus luteum; medicated cycles use estrogen and progesterone with ovulation suppressed. Researchers are studying whether the missing corpus luteum in medicated cycles relates to blood pressure complications, but that question is not settled.

Why did my doctor recommend a freeze-all IVF cycle?

The most common reasons are a strong response to stimulation that raises the risk of ovarian hyperstimulation syndrome, a premature rise in progesterone that could shift the lining’s timing, a plan for genetic testing, or a lining that does not look ready. A freeze-all recommendation is usually a safety or synchronization decision, not a sign that the cycle went badly.

Can embryos be damaged by freezing and thawing?

Under modern vitrification, most embryos survive warming intact, though survival is never guaranteed. Older slow-freezing methods caused ice crystal damage and higher losses, which is where the reputation came from. An embryo that survives thaw behaves like the embryo it was before freezing, and the Cochrane evidence of comparable cumulative live birth supports that.

How long after egg retrieval can a frozen embryo transfer happen?

Often in the next menstrual cycle, once the ovaries have settled and hormones return to baseline, though many teams prefer a longer gap after a strong response or if genetic testing results are pending. The timing also depends on whether a natural or medicated preparation is planned. Your team will set the schedule based on your recovery and your lining.

Does frozen embryo transfer cause bigger babies or high blood pressure?

The Cochrane review found higher reported rates of hypertensive disorders of pregnancy and large-for-gestational-age babies after frozen compared with fresh transfer. The absolute differences are modest and the mechanism is under study. Obstetric teams typically take a frozen-transfer conception into account when planning blood pressure monitoring during pregnancy.

Do I need bed rest after an embryo transfer?

No. Mayo Clinic notes most people can return to normal daily activities after transfer, and bed rest has not been shown to improve outcomes. Prolonged immobility can raise clot risk, which matters especially after a fresh cycle. Your team may ask you to avoid vigorous exercise while the ovaries remain enlarged.

Can the plan change from fresh to frozen during the cycle?

Yes, and it happens often. Teams watch estrogen, progesterone, follicle counts, and lining appearance right up to the trigger, and a finding on the last scan or blood test can tip the decision toward freezing. Asking in advance which results would change the plan makes a same-day switch far less unsettling.

References

• NHS: IVF: What happens
• NHS: IVF: Risks
• MedlinePlus: In vitro fertilization (IVF)

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.